bosentan

Product NDC
70710-1508
11-digit product format
707101508
Labeler code
70710
Product ID
70710-1508_a4b3663e-948c-4d0d-9916-237b5597ad9f
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
bosentan
Dosage form
TABLET, FOR SUSPENSION
Route
ORAL
Labeler
Zydus Pharmaceuticals USA Inc.
Application
ANDA213981
Marketing category
ANDA
Marketing start
2026-02-17
Substance
BOSENTAN
Active strength
32 mg/1
Pharmacologic classes
Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Endothelin Receptor Antagonist [EPC], Endothelin Receptor Antagonists [MoA]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A213981-001BOSENTANBOSENTAN32MGTABLET, FOR SUSPENSION / ORALAB2026-02-17

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
A213981-001AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-08-18 06:07:402026-07A213981-001BOSENTAN32MGTABLET, FOR SUSPENSION / ORALAB2026-02-17caaa826d4ba7…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A213981-001BOSENTAN32MGTABLET, FOR SUSPENSION / ORALAB2026-02-17a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-08-18 06:07:402026-07A213981-001AB1caaa826d4ba7…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A213981-001AB1a50c72e98297…

Additional Listing Data#

Finished product
Yes
Brand name base
bosentan
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
BOSENTAN32 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
Q326023R30Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
1989081Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
c1e75179-cbea-4535-8709-f6d79c1d4004Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
d212b88c-a939-e294-be87-fb95301c9fbbProduct name620251118

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
70710-1508-7bosentan14 in 1 BLISTER PACKTABLET, FOR SUSPENSION141
70710-1508-8bosentan4 in 1 CARTONTABLET, FOR SUSPENSION41

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
70710-1508-8EA - Each70710-15081a141efa-8a26-49ce-9db5-420d57f85ab712026-03-17

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
bosentanBOSENTANZydus Lifesciences Limitedb88cc559-93ae-42db-9c38-fb5e9c4802e62026-02-14Exact identifier
application applno (ANDA): 213981
application number: ANDA213981
bosentanBOSENTANZydus Pharmaceuticals USA Inc.c1e75179-cbea-4535-8709-f6d79c1d40042025-11-12Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 213981
application number: ANDA213981
ndc (product): 70710-1508

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
1989081bosentan 32 MG Tablet for Oral SuspensionPSNc1e75179-cbea-4535-8709-f6d79c1d40041
1989081bosentan 32 MG Tablet for Oral SuspensionSCDc1e75179-cbea-4535-8709-f6d79c1d40041

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
70710-1508-77071015080714 in 1 BLISTER PACKHistorical
70710-1508-8707101508084 BLISTER PACK in 1 CARTON (70710-1508-8) / 14 TABLET, FOR SUSPENSION in 1 BLISTER PACK (70710-1508-7) 4 blister pack2026-02-17NoNoCurrent